WHO ICTRP trial
Bioequivalence study of Sarpogrelate Hydrochloride Tablets in Healthy Male…
ChiCTR-IPR-14005567 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-IPR-14005567 |
|---|---|
| Public title | Bioequivalence study of Sarpogrelate Hydrochloride Tablets in Healthy Male Chinese Volunteers (the fasting state) |
| Scientific title | Bioequivalence study of Sarpogrelate Hydrochloride Tablets in Healthy Male Chinese Volunteers (the fasting state) |
| Primary sponsor | The First Hospital of Jilin University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Anti-thrombosis |
| Interventions | Treatment group :Oral administration of Sarpogrelate Hydrochloride Tablets, 1 piece/time;Control:Oral administration of Sarpogrelate Hydrochloride Tablets, 1Tablet / time |
| Registration date | Nov 3, 2014 |
| Target size | Treatment group :12;Control:12 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: